POMPANO BEACH, Fla., Aug. 14, 2025 (GLOBE NEWSWIRE) — BioStem Technologies, Inc. (“BioStem” or the “Company”) (OTC: BSEM), a leading MedTech company focused on the development, manufacturing, and commercialization of placental-derived products for advanced wound care, today announced the appointment of Brandon Poe as its Chief Financial Officer (CFO). Mr. Poe has served on BioStem’s Board of Directors since 2022. Michael Fortunato, the Company’s …

You can read the full content here